Current Size: 100%


The Ludwig Boltzmann Institute for Hematology and Oncology was launched in 2008 as Ludwig Boltzmann Cluster Oncology (LBC ONC). The foundation of the cluster was based on the consolidation, continuation and expansion of two former Ludwig Boltzmann Institutes in the field of clinical-oncology: Ludwig Boltzmann Institute for Clinical-Experimental Oncology (1) and Ludwig Boltzmann Institute for Leukemia Research and Hematology (2). The combination to a higher-order cluster allowed a scientific focus in the field of preclinical and translational oncology.

In 2018 the LBC ONC was raised to the Ludwig Boltzmann Institut for Hematology and Oncology (LBI HO).